Literature DB >> 2983820

Seroepidemiology of HTLV-III antibodies in a remote population of eastern Zaire.

R J Biggar, M Melbye, L Kestens, M de Feyter, C Saxinger, A J Bodner, L Paluko, W A Blattner, P L Gigase.   

Abstract

A human retrovirus--human T cell lymphotropic virus-III (HTLV-III)--has recently emerged as the probable cause of acquired immunodeficiency syndrome (AIDS). In May 1984, 250 outpatients at a hospital in a remote area of eastern Zaire were surveyed for AIDS type illnesses and the prevalence of antibodies against HTLV-III determined by an enzyme linked immunosorbent assay using disrupted whole HTLV-III virus as the antigen. No clinical cases of AIDS were diagnosed among these patients. Overall, 31 (12.4%) had clearly positive ratios (greater than or equal to 5.0) and a further 30 (12.0%) had borderline ratios (3.0- less than 5.0). Western blots of serum samples from subjects with antibodies yielded bands consistent with HTLV-III as found in American patients with AIDS and members of groups at risk of AIDS. The prevalence of antibody was highest in childhood (p = 0.02); among adults prevalence rose slightly with age. HTLV-III antibodies were more common among the uneducated (p = 0.006), agricultural workers (p = 0.03), and rural residents (p = 0.006), but the Western blot bands were generally weak in this group. By contrast, one urban resident had strong bands. The relatively high prevalence of antibodies among the rural poor in this area of Zaire suggests that HTLV-III or a closely related, cross reactive virus may be endemic in the region. A different natural history of infection, perhaps in childhood, may also explain the findings.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2983820      PMCID: PMC1418595          DOI: 10.1136/bmj.290.6471.808

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  16 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  AIDS and cryptococcosis (Zaire, 1977)

Authors:  J Vandepitte; R Verwilghen; P Zachee
Journal:  Lancet       Date:  1983-04-23       Impact factor: 79.321

3.  AIDS in a Danish surgeon (Zaire, 1976)

Authors:  I C Bygbjerg
Journal:  Lancet       Date:  1983-04-23       Impact factor: 79.321

4.  Acquired immunodeficiency syndrome in African patients.

Authors:  N Clumeck; J Sonnet; H Taelman; F Mascart-Lemone; M De Bruyere; P Vandeperre; J Dasnoy; L Marcelis; M Lamy; C Jonas
Journal:  N Engl J Med       Date:  1984-02-23       Impact factor: 91.245

5.  Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications.

Authors:  S H Weiss; J J Goedert; M G Sarngadharan; A J Bodner; R C Gallo; W A Blattner
Journal:  JAMA       Date:  1985-01-11       Impact factor: 56.272

6.  Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS.

Authors:  M G Sarngadharan; M Popovic; L Bruch; J Schüpbach; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

7.  Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome.

Authors:  F Brun-Vezinet; C Rouzioux; F Barre-Sinoussi; D Klatzmann; A G Saimot; W Rozenbaum; D Christol; J C Gluckmann; L Montagnier; J C Chermann
Journal:  Lancet       Date:  1984-06-09       Impact factor: 79.321

8.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

9.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

Authors:  R C Gallo; S Z Salahuddin; M Popovic; G M Shearer; M Kaplan; B F Haynes; T J Palker; R Redfield; J Oleske; B Safai
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

10.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

Authors:  M Popovic; M G Sarngadharan; E Read; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

View more
  8 in total

1.  Sexually transmitted viral infections in various population groups in Mogadishu, Somalia.

Authors:  H Jama; L Grillner; G Biberfeld; S Osman; A Isse; M Abdirahman; S Bygdeman
Journal:  Genitourin Med       Date:  1987-10

2.  Seroepidemiology of human immunodeficiency virus in Africa.

Authors:  I Wendler; J Schneider; B Gras; A F Fleming; G Hunsmann; H Schmitz
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-27

3.  Clinical epidemiology, not seroepidemiology, is the answer to Africa's AIDS problem.

Authors:  F I Konotey-Ahulu
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-20

4.  HIV 1 and HIV 2 prevalence of seropositivity in a population of West Africa.

Authors:  N Zanchetta; P Viganò; G B Priuli; M P Ferrario; M Zago; A Pagano
Journal:  Eur J Epidemiol       Date:  1990-03       Impact factor: 8.082

5.  Comparison of enzyme immunoassays and an immunofluorescence test for detection of antibody to human immunodeficiency virus in African sera.

Authors:  G Vercauteren; G van der Groen; P Piot
Journal:  Eur J Clin Microbiol       Date:  1987-04       Impact factor: 3.267

Review 6.  Infectious diseases in Africa.

Authors:  E A Ayoola
Journal:  Infection       Date:  1987 May-Jun       Impact factor: 3.553

7.  Development of a Sensitive and Specific Serological Assay Based on Luminex Technology for Detection of Antibodies to Zaire Ebola Virus.

Authors:  Ahidjo Ayouba; Abdoulaye Touré; Christelle Butel; Alpha Kabinet Keita; Florian Binetruy; Mamadou S Sow; Vincent Foulongne; Eric Delaporte; Martine Peeters
Journal:  J Clin Microbiol       Date:  2016-12-28       Impact factor: 5.948

8.  Epidemiological evidence that HTLV-III is the AIDS agent.

Authors:  J J Goedert; R C Gallo
Journal:  Eur J Epidemiol       Date:  1985-09       Impact factor: 8.082

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.